Vulvar cancer is a type of malignant tumor in women. For patients in the early stages of vulvar cancer, chemotherapy is generally not required after radical surgery. Even without chemotherapy, the disease progression of early-stage vulvar cancer is relatively slow, and many patients can achieve clinical cure after the radical surgery. However, for patients with mid-to-late stage vulvar cancer, postoperative adjuvant chemotherapy is generally required after the radical surgery to reduce the chances of disease recurrence and metastasis. Without postoperative adjuvant chemotherapy, the disease can spread quickly, and many patients soon experience the spread of the disease, eventually leading to multi-organ failure and death. Therefore, it is essential for patients who need adjuvant chemotherapy to complete the supplementary treatment regularly and on time after surgery.